Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > Hydrogels: MRSA superbugs and wound healing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2016)
•••
Post by Ciaoon Oct 26, 2022 9:38pm
175 Views
Post# 35051896

Hydrogels: MRSA superbugs and wound healing

Hydrogels: MRSA superbugs and wound healingMcMaster is also helping with research against MRSA superbugs, this was noted in 2019.
https://brighterworld.mcmaster.ca/articles/studentspostdocsfacultyindustrysolutions-to-big-challenges/

An "update" was given in Q1 this year.
As an example, drug delivery systems composed of PGX processed cross-linked alginate impregnated with different antibiotics were recently developed and tested both in vitro and in vivo for wound healing applications. Clear zones of inhibition were seen for all in vitro tests, while a disc of cross-linked alginate impregnated with fusidic acid successfully inhibited Methicillin-Resistant Staphylococcus aureus (MRSA) infection in wounds in mice.

Another application for hydrogels is the use in scaffolds for tissue strutural support. Wound healing in mice was improved when PGX hydrogels were loaded with ibuprohen as recently detailed in the HCW May webcast.

Are more pre-clinical studies needed? Would a pharma partner take these potential applications to phase 1 studies now that a cost effective PGX alginate based carrier is available? 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities